1-7 of 7
Deepa B. Shankar
Close
Sort by
Journal Articles

CREB is a critical regulator of normal hematopoiesis and leukemogenesis

Jerry C. Cheng, Kentaro Kinjo, Dejah R. Judelson, Jenny Chang, Winston S. Wu, Ingrid Schmid, Deepa B. Shankar, Noriyuki Kasahara, Renata Stripecke, Ravi Bhatia, Elliot M. Landaw, Kathleen M. Sakamoto
Journal: Blood
Blood (2008) 111 (3): 1182–1192.
https://doi.org/10.1182/blood-2007-04-083600
Published: 2008
Includes: Supplemental data
Journal Articles

ABT-869, a multitargeted receptor tyrosine kinase inhibitor: inhibition of FLT3 phosphorylation and signaling in acute myeloid leukemia

Deepa B. Shankar, Junling Li, Paul Tapang, J. Owen McCall, Lori J. Pease, Yujia Dai, Ru-Qi Wei, Daniel H. Albert, Jennifer J. Bouska, Donald J. Osterling, Jun Guo, Patrick A. Marcotte, Eric F. Johnson, Niru Soni, Kresna Hartandi, Michael R. Michaelides, Steven K. Davidsen, Saul J. Priceman, Jenny C. Chang, Katrin Rhodes, Neil Shah, Theodore B. Moore, Kathleen M. Sakamoto, Keith B. Glaser
Journal: Blood
Blood (2007) 109 (8): 3400–3408.
https://doi.org/10.1182/blood-2006-06-029579
Published: 2007
Includes: Supplemental data
Journal Articles

CREB Transgenic Mice Develop Myeloproliferative Disease/Myelodysplastic Syndrome after a Prolonged Latency.

Deepa B. Shankar, PhD, Kentaro Kinjo, MD, PhD, Jenny Chang, BS, Kathleen M. Sakamoto, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 367.
https://doi.org/10.1182/blood.V106.11.367.367
Published: 2005
Journal Articles

The Multi-Targeted Receptor Tyrosine Kinase Inhibitor, ABT-869, Induces Apoptosis of AML Cells Both In Vitro and In Vivo.

Deepa B. Shankar, PhD, Jenny C. Chang, Bertrand Parcells, Salemiz Sandoval, Junling Li, Ru-Qi Wei, Paul Tapang, Steven K. Davidsen, PhD, Dan H. Albert, PhD, Keith B. Glaser, PhD, Theodore B. Moore, MD, Kathleen M. Sakamoto, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 616.
https://doi.org/10.1182/blood.V106.11.616.616
Published: 2005
Journal Articles

Cyclin A Is a Target Gene of Activated CREB Downstream of GM-CSF Signaling That Regulates Normal and Malignant Myelopoiesis.

Deepa B. Shankar, Ph.D., Kentaro Kinjo, M.D., Ph.D., Jerry Cheng, M.D., Samuel Esparza, M.D., Noah Federman, M.D., Theodore B. Moore, M.D., Kathleen M. Sakamoto, M.D., Ph.D.
Journal: Blood
Blood (2004) 104 (11): 2181.
https://doi.org/10.1182/blood.V104.11.2181.2181
Published: 2004
Journal Articles

CREB Overexpression In Vivo Results in Increased Proliferation, Blast Transformation, and Earlier Engraftment of Myeloid Progenitor Cells.

Kentaro Kinjo, M.D., Ph.D., Deepa B. Shankar, Ph.D., Jerry Cheng, M.D., Samuel Esparza, M.D., Noah Federman, M.D., Theodore B. Moore, M.D., Kathleen M. Sakamoto, M.D., Ph.D.
Journal: Blood
Blood (2004) 104 (11): 3548.
https://doi.org/10.1182/blood.V104.11.3548.3548
Published: 2004
Journal Articles

CREB Is Amplified in AML Blasts and Is Associated with an Increased Risk of Relapse and Decreased Event-Free Survival.

Deepa B. Shankar, Ph.D., Elliot M. Landaw, M.D., Ph.D., Nagesh Rao, Ph.D., Theodore B. Moore, M.D., Kathleen M. Sakamoto, M.D., Ph.D.
Journal: Blood
Blood (2004) 104 (11): 573.
https://doi.org/10.1182/blood.V104.11.573.573
Published: 2004